ARCHIVES

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

Newest NIH Institute, NIBIB, Gets An Acting Director.

May 11, 2001

In Brief: Bristol Dedicates New Research center; MSK Presents Awards to Sen. Moyniham, 10 Others

July 11, 1986

Gardasil Approved To Prevent Vulvar And Vaginal Cancers

September 26, 2008

In Brief: Appropriations Hearings Scheduled; Zubro Heads AACI, Nelson Elected ACCC President

February 10, 1978

New Design For NCI’s CancerNet Wins Prestigious Web Site Design Awards.

November 17, 2000

“NIH Reveres, Honors, respects And Defends One And Only One Mechanisms’ – R01s

September 20, 1991